To elucidate the role of ECRG4 hypermethylation in human tumor cells, we analyzed the methylation of its promoter in eleven cancer cell lines from colorectal, lung, cervix, hepatocellular and breast carcinoma, fibrosarcoma and glioblastoma (Table 1). The gene discussed is ECRG4; the disease is glioblastoma.